Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Prelude Therapeutics Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 68 | 2 | 62 | −4 |
| Shares | 34.1M | 58.5K | 32.7M | −1.31M (−3.9%) |
| Value | $235.4M | $404.0K | $170.9M | −$64.1M (−27.3%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caxton Associates LP | 83,867 | $438.0K | 0.05% |
| New York Life Investment Management LLC | 67,585 | $353.0K | 0.00% |
| Bridgeway Capital Management, LLC | 46,949 | $245.0K | 0.01% |
| Ergoteles LLC | 43,500 | $227.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 39,938 | $208.0K | 0.00% |
| Susquehanna International Group, LLP | 29,428 | $154.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 18,000 | $94.0K | 0.00% |
| Delphia (USA) Inc. | 16,940 | $88.0K | 0.06% |
| Nisa Investment Advisors, LLC | 4,000 | $21.0K | 0.00% |
| Quantbot Technologies LP | 2,800 | $14.0K | 0.00% |
| Federated Hermes, Inc. | 266 | $1.00K | 0.00% |
| Credit Suisse AG | 6 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 11 | $0 | 0.00% |
Sold out (17)
Institutions that held Prelude Therapeutics Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Nuveen Asset Management, LLC | 66,421 | $490.0K |
| Swiss National Bank | 29,700 | $205.0K |
| Alliancebernstein L.P. | 21,500 | $148.0K |
| California State Teachers Retirement System | 15,316 | $106.0K |
| Voloridge Investment Management, LLC | 11,743 | $81.0K |
| Rhumbline Advisers | 10,050 | $69.0K |
| Deutsche Bank AG | 6,187 | $43.0K |
| American International Group, Inc. | 5,373 | $37.0K |
| Legal & General Group Plc | 3,914 | $27.0K |
| STRS Ohio | 2,200 | $15.0K |
| Amalgamated Bank | 1,764 | $12.0K |
| Lindbrook Capital, LLC | 1,562 | $11.0K |
| Simplex Trading, LLC | 1,561 | $10.0K |
| Signaturefd, LLC | 992 | $7.00K |
| Ameritas Investment Partners, Inc. | 769 | $5.00K |
| Dravo Bay LLC | 650 | $4.49K |
| US Bancorp | 606 | $4.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Prelude Therapeutics Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| IndexIQ Advisors LLC | 56,750 | $392.0K |
| Amalgamated Financial Corp. | 1,764 | $12.0K |